BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Retnakumar SV, Muller S. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends Mol Med 2019;25:516-37. [PMID: 30952481 DOI: 10.1016/j.molmed.2019.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Muller S. The abscopal effect: Implications for drug discovery in autoimmunity. Autoimmun Rev 2023;:103315. [PMID: 36924921 DOI: 10.1016/j.autrev.2023.103315] [Reference Citation Analysis]
2 Gros F, Muller S. The role of lysosomes in metabolic and autoimmune diseases. Nat Rev Nephrol 2023. [PMID: 36894628 DOI: 10.1038/s41581-023-00692-2] [Reference Citation Analysis]
3 Zudeh G, Franca R, Lucafò M, Bonten EJ, Bramuzzo M, Sgarra R, Lagatolla C, Franzin M, Evans WE, Decorti G, Stocco G. PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells. Life Sci Alliance 2023;6. [PMID: 36596605 DOI: 10.26508/lsa.202201610] [Reference Citation Analysis]
4 Wei S, Zhang J, Wu X, Chen M, Huang H, Zeng S, Xiang Z, Li X, Dong W. Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis. Inflamm Bowel Dis 2023;29:9-26. [PMID: 35998069 DOI: 10.1093/ibd/izac177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lu X, Zhang J, Ding Y, Wu J, Chen G. Novel Therapeutic Strategies for Ischemic Stroke: Recent Insights into Autophagy. Oxid Med Cell Longev 2022;2022:3450207. [PMID: 35720192 DOI: 10.1155/2022/3450207] [Reference Citation Analysis]
6 Hong J, Pandurangan A. Protective Effects of Curcumin-Regulated Intestinal Epithelial Autophagy on Inflammatory Bowel Disease in Mice. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/2163931] [Reference Citation Analysis]
7 Retnakumar SV, Geesala R, Bretin A, Tourneur-Marsille J, Ogier-Denis E, Maretzky T, Thu Nguyen HT, Muller S. Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. J Autoimmun 2022;128:102814. [PMID: 35298976 DOI: 10.1016/j.jaut.2022.102814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qiu P, Liu L, Fang J, Zhang M, Wang H, Peng Y, Chen M, Liu J, Wang F, Zhao Q. Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis. Front Pharmacol 2021;12:769718. [PMID: 34925026 DOI: 10.3389/fphar.2021.769718] [Reference Citation Analysis]
9 Zhang Y, Li X, Li Y, Li Y, Wang Y, Zhu L, Chen P, Tian Z, Qiu Y, Feng R, Zeng Z, He Y, Chen B, Zhang S, Mao R, Chen M. DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease. Dig Dis Sci 2021;66:3375-90. [PMID: 33184797 DOI: 10.1007/s10620-020-06697-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lv Q, Xing Y, Liu J, Dong D, Liu Y, Qiao H, Zhang Y, Hu L. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation. Acta Pharm Sin B 2021;11:2880-99. [PMID: 34589402 DOI: 10.1016/j.apsb.2021.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
11 Li N, Zhan S, Tian Z, Liu C, Xie Z, Zhang S, Chen M, Zeng Z, Zhuang X. Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1525-40. [PMID: 33399195 DOI: 10.1093/ibd/izaa342] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
12 Misselwitz B, Juillerat P, Sulz MC, Siegmund B, Brand S; Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More. Digestion 2020;101 Suppl 1:69-82. [PMID: 32570252 DOI: 10.1159/000507782] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
13 Wang D, Shao S, Zhang Y, Zhao D, Wang M. Insight Into Polysaccharides From Panax ginseng C. A. Meyer in Improving Intestinal Inflammation: Modulating Intestinal Microbiota and Autophagy. Front Immunol 2021;12:683911. [PMID: 34354704 DOI: 10.3389/fimmu.2021.683911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Thein W, Po WW, Choi WS, Sohn UD. Autophagy and Digestive Disorders: Advances in Understanding and Therapeutic Approaches. Biomol Ther (Seoul) 2021;29:353-64. [PMID: 34127572 DOI: 10.4062/biomolther.2021.086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Liu Y, Liao R, Qiang Z, Yang W, Cao J, Zeng H. Exogenous H2S Protects Colon Cells in Ulcerative Colitis by Inhibiting NLRP3 and Activating Autophagy. DNA Cell Biol 2021;40:748-56. [PMID: 33983842 DOI: 10.1089/dna.2020.6380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Arab HH, Al-Shorbagy MY, Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways. Chem Biol Interact 2021;335:109368. [PMID: 33412153 DOI: 10.1016/j.cbi.2021.109368] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
17 Pippis EJ, Yacyshyn BR. Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD. Inflamm Bowel Dis 2021;27:1674-83. [PMID: 33295611 DOI: 10.1093/ibd/izaa318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Yin L, Xia Y, Xu P, Zheng W, Gao Y, Xie F, Ji Z. Veratramine suppresses human HepG2 liver cancer cell growth in vitro and in vivo by inducing autophagic cell death. Oncol Rep 2020;44:477-86. [PMID: 32468056 DOI: 10.3892/or.2020.7622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
19 Bonam SR, Bayry J, Tschan MP, Muller S. Progress and Challenges in The Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo. Cells 2020;9:E1321. [PMID: 32466347 DOI: 10.3390/cells9051321] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
20 Kang SB, Yoo HS, Jeon SH, Song CW, Lee NR, Kim NJ, Lee JK, Inn KS. Identification of 3',4',5'-trihydroxyflavone as an mammalian target of rapamycin inhibitor and its suppressive effects on dextran sulfate sodium-induced ulcerative colitis. Int Immunopharmacol 2020;84:106524. [PMID: 32334388 DOI: 10.1016/j.intimp.2020.106524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Liu J, Cai J, Fan P, Zhang N, Cao Y. The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced Nucleotide Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3/Autophagy, and Maintaining Intestinal Barrier Are Profitable in Colitis. Front Pharmacol. 2019;10:1385. [PMID: 31849652 DOI: 10.3389/fphar.2019.01385] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
22 Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov 2019;18:923-48. [PMID: 31477883 DOI: 10.1038/s41573-019-0036-1] [Cited by in Crossref: 204] [Cited by in F6Publishing: 215] [Article Influence: 51.0] [Reference Citation Analysis]
23 Bonam SR, Ruff M, Muller S. HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates. Cells 2019;8:E849. [PMID: 31394830 DOI: 10.3390/cells8080849] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]